CUSIP: 92189F387
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHRT HGH YLD MUN
-
Total 13F shares
-
1,910,512
-
Share change
-
-183,926
-
Total reported value
-
$46,386,000
-
Price per share
-
$24.28
-
Number of holders
-
36
-
Value change
-
-$4,439,837
-
Number of buys
-
18
-
Number of sells
-
15
Security key
92189F387
Report period
Q2 2017
Institutions
36
Top holders
10
Reporting periods
Holder history for CUSIP 92189F387
Recent filing periods:
Top shareholders of SHYD - VANECK ETF TRUST - SHRT HGH YLD MUN (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) as of Q2 2017
As of 30 Jun 2017,
VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,910,512 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, UBS Group AG, MORGAN STANLEY, Bank of New York Mellon Corp, ROYAL BANK OF CANADA, Tortoise Investment Management, LLC, New England Investment & Retirement Group, Inc., WELLS FARGO & COMPANY/MN, FLOW TRADERS U.S. LLC, and JANE STREET GROUP, LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2017 vs Q1 2017 Across Filers
| Investor |
Q1 2017 Shares |
Q2 2017 Shares |
Share Diff |
Share Chg % |
Q1 2017 Value $ |
Q2 2017 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.